Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Anthera Pharmaceuticals Inc (NASDAQ:ANTH)

2.92
Delayed Data
As of 2:43pm ET
 -0.03 / -1.02%
Today’s Change
2.28
Today|||52-Week Range
10.00
-37.07%
Year-to-Date

Today’s Trading

Previous close2.95
Today’s open2.97
Day’s range2.88 - 3.08
Volume475,386
Average volume (3 months)507,965
Market cap$122.2M
Dividend yield--
Data as of 2:43pm ET, 08/26/2016

Growth & Valuation

Earnings growth (last year)+27.21%
Earnings growth (this year)-36.45%
Earnings growth (next 5 years)+78.00%
Revenue growth (last year)--
P/E ratioNM
Price/Sales51.91
Price/Book2.98

Competitors

 Today’s
change
Today’s
% change
DPRXDipexium Pharmaceuti...+0.59+5.11%
ECYTEndocyte Inc-0.04-1.32%
MSLIMerus Labs Internati...0.000.00%
TTNPTitan Pharmaceutical...-0.05-1.01%
Data as of 2:43pm ET, 08/26/2016

Financials

Next reporting dateOctober 19, 2016
EPS forecast (this quarter)-$0.36
Annual revenue (last year)$3.2M
Annual profit (last year)-$35.2M
Net profit margin-1,105.81%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Paul F. Truex
President &
Chief Operating Officer
John Craig Thompson
Corporate headquarters
Hayward, California

Forecasts

Partner Offers

Search for Jobs